On the stock market since 1985, it operates in the world of real estate. It has 411 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 10% a year over the last 4 years. Every year shown ended in profit.
The gap is $9.9B. In times of high interest rates, a gap like that can squeeze a company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
Clearly below the class average.
Clearly below the class average.
The stock has been running stronger than the market lately.
Growth: Sales growth trails the sector average.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
The stock trades 42% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 11% a year on average.
Over the last 12 months, company executives reported 35 buys and 14 sells. Management buying with its own money is usually read as a good sign.
It pays out $1.22 per share each year — regular cash for whoever holds the stock.
The company’s market value is 207 times its annual profit. Even a small disappointment could hit the price hard.
The growth engine is running at low revs right now. Report-card grade: 41/100.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 47/100.
On our five-subject report card, DOC sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: DOC is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.